Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2025-02-20 Investor Presentation
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter dated February 20, 2025, addressed to stock exchanges regarding the company's participation in upcoming investor conferences. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The letter states that no new presentation will be made at the conferences and provides a link to the latest investor presentation already available on the company's website. The document is short (1663 characters) and serves as an announcement of participation in investor conferences rather than the presentation itself or a detailed financial report. Therefore, it is best classified as an Investor Presentation announcement or update. However, since no new presentation is being made and this is an intimation of participation, the most appropriate classification is Investor Presentation (IP) because the document focuses on investor relations and presentations, not a regulatory filing or report publication announcement.
2025-02-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter dated February 20, 2025, addressed to stock exchanges regarding the company's participation in upcoming investor conferences. It references compliance with SEBI Listing Obligations and Disclosure Requirements, 2015, and provides a schedule of investor conference events. It explicitly states that no new presentation will be made at these conferences and that the latest investor presentation is already available on the company's website. The document is informational and does not contain financial data, earnings, or detailed report content. It is an announcement about investor events and presentations rather than the presentation itself or a financial report. Given the nature of the content, this fits best under the category of Investor Presentation (IP) as it relates to investor communications and presentations, even though no new presentation is being made, the document is about investor presentations and conferences. The document length is short (1663 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is Investor Presentation (IP) with high confidence.
2025-02-20 English
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is an official communication dated February 18, 2025, addressed to stock exchanges (BSE and NSE) regarding the completion of the term of an Independent Director, Mr. Surendra Lunia. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 30 and 51, which pertain to disclosure of events or information about the company. The content focuses on the cessation of the director's term and includes an annexure with details about the change. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management discussion. The document is clearly an announcement about a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and does not contain any financial statements or detailed reports, so it is not an Annual Report or Interim Report. It is not a Regulatory Filing (RNS) because it specifically relates to a board change and complies with listing regulations for such disclosures.
2025-02-18 English
Integrated Filing- Financial
Regulatory Filings
2025-02-17 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a brief communication addressed to stock exchanges regarding the completion of a stake sale transaction involving Mahananda Spa and Resorts Private Limited. It references a Share Purchase Agreement execution and provides financial details of the transaction. The document cites compliance with SEBI Listing Regulations and refers to an earlier detailed disclosure. The content is an update on a capital transaction rather than a full financial report or earnings release. The document length is short (1658 characters), and it is clearly an announcement of a financing-related event (stake sale). Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-02-11 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official notification under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the sale of the entire stake in a subsidiary company. It includes details about the transaction such as the buyer, consideration, and expected completion date. The document is an announcement of a material event related to the company's capital structure and asset monetization, specifically the sale of a subsidiary. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4588 characters, which is consistent with a detailed announcement rather than a full report.
2025-02-10 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.